S5444 Fulminant Liver Failure in Multiple Myeloma Without Light Chain Deposition Disease

Introduction: Portal hypertension is commonly caused by cirrhosis, but non-cirrhotic mechanisms can also elevate portal venous pressure known as non-cirrhotic portal hypertension (NCPH). NCPH can result from vascular malignancies or hematologic conditions. This includes neoplastic plasma cell dyscrasias like multiple myeloma, and typically have plasma cell infiltration on liver biopsy. Gastric varices are a life threatening complication of portal hypertension and acute liver failure. We present a case of a gastric variceal bleeding in a patient with acute liver failure from multiple myeloma, without commonly described liver biopsy findings. Case Description/Methods: A 51-year-old man with a history of smoldering multiple myeloma presented for melena for one month and a hemoglobin of 4.7 g/dL. The patient denied any history of cirrhosis, alcohol use, medications or prior liver disease. The patient was never treated with chemotherapy for his multiple myeloma. Esophagogastroduodenoscopy (EGD) revealed large gastric varices with high-risk stigmata of bleeding, that subsequently bled during the procedure and was treated with hemospray. The patient underwent urgent transhepatic embolization of gastric varices. During access to one of the varices, perforation and bleeding occurred and was treated with plug and gelfoam embolization. Computed tomography of the abdomen revealed a patent portal vein and signs of portal hypertension without obvious signs of cirrhosis. Laboratory evaluation revealed pancytopenia, normal clotting time, normal liver enzymes, and hypoalbuminemia. Measurement of the trans-sinusoidal porto-systemic pressure gradient was elevated to 13 mm Hg, confirming portal hypertension. A liver biopsy demonstrated nonspecific mild chronic hepatitis, sinusoidal dilation, and periportal fibrosis. Discussion: This case illustrates a clinically challenging presentation of NCPH in a patient with smoldering multiple myeloma. The presence of periportal fibrosis and sinusoidal dilation suggests the NCPH may be related to sinusoidal injury in multiple myeloma. However, the pathologic process may be patchy, focal or submicroscopic, and not always seen on liver biopsy. Additionally, hepatic failure may result from cytokine induced hepatotoxicity, contributing to liver dysfunction without overt hepatic infiltration on biopsy.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001149236.65975.18
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5444 Fulminant Liver Failure in Multiple Myeloma Without Light Chain Deposition Disease

The American Journal of Gastroenterology
Multiple Myeloma Research and Treatments
article

S5444 Fulminant Liver Failure in Multiple Myeloma Without Light Chain Deposition Disease

article en

Abstract

Introduction: Portal hypertension is commonly caused by cirrhosis, but non-cirrhotic mechanisms can also elevate portal venous pressure known as non-cirrhotic portal hypertension (NCPH). NCPH can result from vascular malignancies or hematologic conditions. This includes neoplastic plasma cell dyscrasias like multiple myeloma, and typically have plasma cell infiltration on liver biopsy. Gastric varices are a life threatening complication of portal hypertension and acute liver failure. We present a case of a gastric variceal bleeding in a patient with acute liver failure from multiple myeloma, without commonly described liver biopsy findings. Case Description/Methods: A 51-year-old man with a history of smoldering multiple myeloma presented for melena for one month and a hemoglobin of 4.7 g/dL. The patient denied any history of cirrhosis, alcohol use, medications or prior liver disease. The patient was never treated with chemotherapy for his multiple myeloma. Esophagogastroduodenoscopy (EGD) revealed large gastric varices with high-risk stigmata of bleeding, that subsequently bled during the procedure and was treated with hemospray. The patient underwent urgent transhepatic embolization of gastric varices. During access to one of the varices, perforation and bleeding occurred and was treated with plug and gelfoam embolization. Computed tomography of the abdomen revealed a patent portal vein and signs of portal hypertension without obvious signs of cirrhosis. Laboratory evaluation revealed pancytopenia, normal clotting time, normal liver enzymes, and hypoalbuminemia. Measurement of the trans-sinusoidal porto-systemic pressure gradient was elevated to 13 mm Hg, confirming portal hypertension. A liver biopsy demonstrated nonspecific mild chronic hepatitis, sinusoidal dilation, and periportal fibrosis. Discussion: This case illustrates a clinically challenging presentation of NCPH in a patient with smoldering multiple myeloma. The presence of periportal fibrosis and sinusoidal dilation suggests the NCPH may be related to sinusoidal injury in multiple myeloma. However, the pathologic process may be patchy, focal or submicroscopic, and not always seen on liver biopsy. Additionally, hepatic failure may result from cytokine induced hepatotoxicity, contributing to liver dysfunction without overt hepatic infiltration on biopsy.

The American Journal of GastroenterologyVol. 120(10S2)
Good health and well-being
Openalex Percentile: Top 27%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

S5444 Fulminant Liver Failure in Multiple Myeloma Without Light Chain Deposition Disease · The American Journal of Gastroenterology (2025) | TGRS Research Map | TGRS